PHI-301

N/A

Report date: 2024/11/22 14:26:03

NME

Base Information

Drug NamePHI-301

Drug Alias NamePHI-301

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionFocal adhesion kinase inhibitors

TargetsFocal adhesion kinase

Therapy Area/IndicationsProstatic NeoplasmsLung Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPharos iBio Co Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsProstatic NeoplasmsLung Neoplasms

Inactive IndicationsN/A

ATC CodeN/A